Age-associated differences in cognitive performance in older patients with schizophrenia

A comparison with healthy older adults

David Loewenstein, Sara J Czaja, Christopher R. Bowie, Philip D Harvey

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

BACKGROUND: There are varying results regarding the conjoint influence of aging and schizophrenia on cognitive abilities. Previous studies have been limited by restricted age ranges among schizophrenia and psychiatrically healthy control samples as well as small numbers of control participants. OBJECTIVE: To quantify the association between age and cognitive performance in patients with schizophrenia and psychiatrically healthy older adult controls and to determine if age-associated changes in cognitive performance were different in the two groups. METHODS: People with schizophrenia (n = 226) and psychiatrically healthy individuals (n = 834) ranging in age from 40 to older than 80 years were compared on a battery of neuropsychological tests. To directly compare the impact of age on cognitive performance, age was also regressed on performance in the two samples. RESULTS: The performance of psychiatrically healthy adults age 70 and older was superior to the performance of the youngest patients with schizophrenia (age 40-49) years on measures of working and episodic memory, executive function, and psychomotor speed. Regression analyses indicated that age effects on cognition were significantly greater for schizophrenia patients on measures of verbal learning and speed of processing. Within both the schizophrenia group, and psychiatrically healthy adults, the greatest age-related differences in performance seemed to occur for individuals aged more than 70 years. CONCLUSION: In this cross-sectional study, the present findings underscore the fact that schizophrenia is associated with cognitive impairment across all ages and that older schizophrenia patients experience relatively greater age associated differences in cognitive functioning than healthy individuals. These findings have wide-ranging implications regarding the ability of older patients with schizophrenia to function independently and for the development of treatment strategies.

Original languageEnglish
Pages (from-to)29-40
Number of pages12
JournalAmerican Journal of Geriatric Psychiatry
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Schizophrenia
Aptitude
Verbal Learning
Episodic Memory
Neuropsychological Tests
Executive Function
Short-Term Memory
Cognition
Cross-Sectional Studies
Regression Analysis

Keywords

  • aging
  • cognitive decline
  • cognitive impairment

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology

Cite this

Age-associated differences in cognitive performance in older patients with schizophrenia : A comparison with healthy older adults. / Loewenstein, David; Czaja, Sara J; Bowie, Christopher R.; Harvey, Philip D.

In: American Journal of Geriatric Psychiatry, Vol. 20, No. 1, 01.01.2012, p. 29-40.

Research output: Contribution to journalArticle

@article{ade1db2f9af44119ab9bc0d807c70769,
title = "Age-associated differences in cognitive performance in older patients with schizophrenia: A comparison with healthy older adults",
abstract = "BACKGROUND: There are varying results regarding the conjoint influence of aging and schizophrenia on cognitive abilities. Previous studies have been limited by restricted age ranges among schizophrenia and psychiatrically healthy control samples as well as small numbers of control participants. OBJECTIVE: To quantify the association between age and cognitive performance in patients with schizophrenia and psychiatrically healthy older adult controls and to determine if age-associated changes in cognitive performance were different in the two groups. METHODS: People with schizophrenia (n = 226) and psychiatrically healthy individuals (n = 834) ranging in age from 40 to older than 80 years were compared on a battery of neuropsychological tests. To directly compare the impact of age on cognitive performance, age was also regressed on performance in the two samples. RESULTS: The performance of psychiatrically healthy adults age 70 and older was superior to the performance of the youngest patients with schizophrenia (age 40-49) years on measures of working and episodic memory, executive function, and psychomotor speed. Regression analyses indicated that age effects on cognition were significantly greater for schizophrenia patients on measures of verbal learning and speed of processing. Within both the schizophrenia group, and psychiatrically healthy adults, the greatest age-related differences in performance seemed to occur for individuals aged more than 70 years. CONCLUSION: In this cross-sectional study, the present findings underscore the fact that schizophrenia is associated with cognitive impairment across all ages and that older schizophrenia patients experience relatively greater age associated differences in cognitive functioning than healthy individuals. These findings have wide-ranging implications regarding the ability of older patients with schizophrenia to function independently and for the development of treatment strategies.",
keywords = "aging, cognitive decline, cognitive impairment",
author = "David Loewenstein and Czaja, {Sara J} and Bowie, {Christopher R.} and Harvey, {Philip D}",
year = "2012",
month = "1",
day = "1",
doi = "10.1097/JGP.0b013e31823bc08c",
language = "English",
volume = "20",
pages = "29--40",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Age-associated differences in cognitive performance in older patients with schizophrenia

T2 - A comparison with healthy older adults

AU - Loewenstein, David

AU - Czaja, Sara J

AU - Bowie, Christopher R.

AU - Harvey, Philip D

PY - 2012/1/1

Y1 - 2012/1/1

N2 - BACKGROUND: There are varying results regarding the conjoint influence of aging and schizophrenia on cognitive abilities. Previous studies have been limited by restricted age ranges among schizophrenia and psychiatrically healthy control samples as well as small numbers of control participants. OBJECTIVE: To quantify the association between age and cognitive performance in patients with schizophrenia and psychiatrically healthy older adult controls and to determine if age-associated changes in cognitive performance were different in the two groups. METHODS: People with schizophrenia (n = 226) and psychiatrically healthy individuals (n = 834) ranging in age from 40 to older than 80 years were compared on a battery of neuropsychological tests. To directly compare the impact of age on cognitive performance, age was also regressed on performance in the two samples. RESULTS: The performance of psychiatrically healthy adults age 70 and older was superior to the performance of the youngest patients with schizophrenia (age 40-49) years on measures of working and episodic memory, executive function, and psychomotor speed. Regression analyses indicated that age effects on cognition were significantly greater for schizophrenia patients on measures of verbal learning and speed of processing. Within both the schizophrenia group, and psychiatrically healthy adults, the greatest age-related differences in performance seemed to occur for individuals aged more than 70 years. CONCLUSION: In this cross-sectional study, the present findings underscore the fact that schizophrenia is associated with cognitive impairment across all ages and that older schizophrenia patients experience relatively greater age associated differences in cognitive functioning than healthy individuals. These findings have wide-ranging implications regarding the ability of older patients with schizophrenia to function independently and for the development of treatment strategies.

AB - BACKGROUND: There are varying results regarding the conjoint influence of aging and schizophrenia on cognitive abilities. Previous studies have been limited by restricted age ranges among schizophrenia and psychiatrically healthy control samples as well as small numbers of control participants. OBJECTIVE: To quantify the association between age and cognitive performance in patients with schizophrenia and psychiatrically healthy older adult controls and to determine if age-associated changes in cognitive performance were different in the two groups. METHODS: People with schizophrenia (n = 226) and psychiatrically healthy individuals (n = 834) ranging in age from 40 to older than 80 years were compared on a battery of neuropsychological tests. To directly compare the impact of age on cognitive performance, age was also regressed on performance in the two samples. RESULTS: The performance of psychiatrically healthy adults age 70 and older was superior to the performance of the youngest patients with schizophrenia (age 40-49) years on measures of working and episodic memory, executive function, and psychomotor speed. Regression analyses indicated that age effects on cognition were significantly greater for schizophrenia patients on measures of verbal learning and speed of processing. Within both the schizophrenia group, and psychiatrically healthy adults, the greatest age-related differences in performance seemed to occur for individuals aged more than 70 years. CONCLUSION: In this cross-sectional study, the present findings underscore the fact that schizophrenia is associated with cognitive impairment across all ages and that older schizophrenia patients experience relatively greater age associated differences in cognitive functioning than healthy individuals. These findings have wide-ranging implications regarding the ability of older patients with schizophrenia to function independently and for the development of treatment strategies.

KW - aging

KW - cognitive decline

KW - cognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=84155163269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84155163269&partnerID=8YFLogxK

U2 - 10.1097/JGP.0b013e31823bc08c

DO - 10.1097/JGP.0b013e31823bc08c

M3 - Article

VL - 20

SP - 29

EP - 40

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 1

ER -